Clinical feasibility of pulmonary vein orifice pacing for the prediction of phrenic nerve injury during cryoballoon ablation of atrial fibrillation.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
08 2019
Historique:
received: 03 03 2019
revised: 08 04 2019
accepted: 29 04 2019
pubmed: 3 5 2019
medline: 29 9 2020
entrez: 3 5 2019
Statut: ppublish

Résumé

Phrenic nerve (PN) injury is a well-known complication of cryoballoon ablation (CBA) for pulmonary vein (PV) isolation in patients with atrial fibrillation. However, it is still insufficient to practically predict phrenic nerve injury (PNI) before freezing. We hypothesized that phrenic nerve capture (PNC) with phrenic nerve orifice pacing (PVOP) might be a surrogate sign of the close proximity of the PN, and that might predict PNI and changes in the compound motor action potential (CMAP) amplitude. Seventy patients (60 ± 12 years, male 80%, paroxysmal 56%) underwent PVOP with a 20-electrode ring catheter before the CBA. The clinical outcome was the occurrence of transient and persistent PNI. In addition, the PV position and pacing threshold during PNC with PVOP, and changes in the CMAP amplitude were recorded. We compared these measurements between patients with and without PNC (PNC/non-PNC group) with PVOP. PNC with PVOP occurred in 39 (56%) patients and was localized only to the right superior PV. Transient PNI occurred in seven (10%) patients and permanent in none. The CMAP amplitude decreased significantly more in the PNC group (PNC 33% vs non-PNC 16%, P = .027). PNC group had a higher risk of the composite outcome of transient PNI or ≥30% decrease in the CMAP amplitude (PNC 54% vs non-PNC 13%; P < .001). This PVOP technique could be feasible and contribute to predicting transient PNI and CMAP amplitude reductions before cryoapplications. Further studies are necessary to elucidate the additional efficacy of PVOP over CMAP monitoring alone.

Identifiants

pubmed: 31045300
doi: 10.1111/jce.13962
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1200-1206

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Makoto Sano (M)

Department of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Tsuyoshi Urushida (T)

Department of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Gaku Matsukura (G)

Department of Cardiology, Hamamatsu Red Cross Hospital, Hamamatsu, Japan.

Tomoaki Sakakibara (T)

Department of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Kenichiro Suwa (K)

Department of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Yoshihisa Naruse (Y)

Department of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Hayato Ohtani (H)

Department of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Masao Saotome (M)

Department of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Yuichiro Maekawa (Y)

Department of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH